baber/WOPTO huggingface dataset:
Patent DE-69512027-D1 (DE)
Inventor: DOERFEL WALTER
IPC: B65H18/00
Filed: 1995-01-31
Granted: 1999-10-14
Abstract: PCT No. PCT/EP95/00330 Sec. 371 Date Jul. 25, 1996 Sec. 102(e) Date Jul. 25, 1996 PCT Filed Jan. 31, 1995 PCT Pub. No. WO95/21118 PCT Pub. Date Aug. 10, 1995A system to achieve an improved winding structure while winding webs (1, 1', 1'' . . . ), especially paper webs, to obtain at least one wound web roll (5, 5', 5'' . . . ) on a winding machine, comprises sensors 8A, 9A for determining torque load 8 and rider roll nip load 9, respectively, in order to change the tension remaining in the wound web. The winding machine is of a supporting drum type with at least two supporting drums (2, 3), at least one of these supporting drums preferably has elastic flexible surface (2', 3'). The torque and nip loads 8, 9, respectively, for changing the tension remaining in the wound web roll operate such that the tension of the web (1, 1', 1'' . . . ) first decreases at increasing web roll diameter of said at least one web roll (5, 5', 5'' . . .) during an initial winding phase, then stays approximately at the same level and, after winding further, decreases further at increasing wound web roll diameter during a final winding phase.
Patent DE-69516903-D1 (DE)
Inventor: BOEHM F
IPC: C07C59/64
Filed: 1995-12-21
Granted: 2000-06-15
Abstract: Novel trienoic retinoid compounds having activity for retinoic acid receptors and retinoid X receptors are provided. Also provided are pharmaceutical compositions incorporating such compounds and methods for their use.
Patent DE-69521717-D1 (DE)
Inventor: KATO MUNEYOSHI
IPC: A61K9/127
Filed: 1995-12-19
Granted: 2001-08-16
Abstract: ÄObjectÜ To provide eye drops which have excellent treating and mitigating effects on symptoms caused by dry eye. ÄConstitutionÜ Liposome eye drops comprising taurine, glucose and inorganic salts.
Patent DE-69523737-D1 (DE)
Inventor: DALRYMPLE JON
IPC: A61C1/05
Filed: 1995-02-02
Granted: 2001-12-13
Abstract: Dental hand tools including disposable water and air treatment cartridges. In various constructions, cartridges containing selected arrangements of disinfectant media mount to a detachable, hand tool adaptor manifold or to an integral hand tool manifold. The cartridges purify water and air discharged from the hand tool of undesired microbes and pathogens. Seals at a cartridge body retain the cartridge to the manifold and direct liquid and air flow over external surfaces of the cartridge to an interior cavity containing a halogen disinfectant media (e.g. a multi-valent iodine resin) and/or halogen scavenger media and porous spacers. A retainer may interlock the cartridge to the manifold and means may be included to prevent leaching of the disinfectant by the scavenger media. Various constructions of handpieces, syringes and scalers compatible with alternative adaptors or having integral cartridge manifolds are disclosed. Spray tips with integral manifolds and detachable cartridge manifolds which align to water and air discharge ports are also disclosed.
Patent DE-69525760-D1 (DE)
Inventor: ROGERS N
IPC: E01C13/08
Filed: 1995-04-20
Granted: 2002-04-11
Abstract: A method for topdressing turfgrass on an activity field with only solid elastomeric particles is described. The method produces turfgrass which has enhanced color and health even when there is extensive abrasion of the grass through use of the field.
Patent DE-69533514-D1 (DE)
Inventor: COVER TIMOTHY L
IPC: C12Q1/68
Filed: 1995-09-29
Granted: 2004-10-21
Abstract: The present invention provides an isolated nucleic acid encoding an approximately 120-128 kilodalton antigen of Helicobacter pylori, or an antigenic fragment thereof, wherein the antigen is associated with peptic ulceration. The present invention also provides methods of detecting the presence of a Helicobacter pylori strain possessing the 120-128 kilodalton antigen in a subject, comprising the steps of contacting an antibody-containing sample from the subject with a detectable amount of the tagA antigen or antigenic polypeptide of the present invention and detecting the binding of the antigen or fragment and the antibody. The detection of a strain expressing the TagA antigen is an indication of predisposition to peptic ulceration and gastric carcinoma. A mutant H. pylori not expressing a functional TagA antigen is also provided.
Patent DE-69533656-D1 (DE)
Inventor: INOUE HAJIME
IPC: H04N7/173
Filed: 1995-08-25
Granted: 2004-11-18
Abstract: A video signal receiver receives a plurality of video channels simultaneously carrying, offset by a transmission interval, a single video program, selects one channel from which to obtain the program for display to a user, and achieves a pause function in the display of the transmitted video program by temporarily storing a segment of the video program equal to the length of the transmission interval and obtaining the remainder of the program at a later time from the same or another channel. <IMAGE>
Patent DE-69533676-D1 (DE)
Inventor: TE RIELE PETRUS
IPC: C12N15/90
Filed: 1995-07-26
Granted: 2004-11-25
Abstract: A mammalian cell having a mismatch repair-deficient phenotype is provided, where one or both alleles of a gene essential for mismatch repair, such as an Msh gene, are inactivated. Using this cell in a gene knock-out methodology advantageously allows efficient homologous recombination, even when the DNA sequences of the donor and recipient sequences diverge by significantly more than 0.6%.
Patent DE-69617719-D1 (DE)
Inventor: BRIEND ROBERT
IPC: A61K31/00
Filed: 1996-10-15
Granted: 2002-01-17
Abstract: PCT No. PCT/FR96/01624 Sec. 371 Date Aug. 10, 1998 Sec. 102(e) Date Aug. 10, 1998 PCT Filed Oct. 17, 1996 PCT Pub. No. WO97/15312 PCT Pub. Date May 1, 1997The invention relates to a method for the treatment or prevention of hypoperfusions of abdominal organs comprising administering a gaseous medication containing nitrogen monoxide and carbon dioxide to the patient. The gaseous medication is administered by the intra-abdominal route.
Patent DE-69626760-D1 (DE)
Inventor: KUNDRAT DAVID M
IPC: C21C7/04
Filed: 1996-11-11
Granted: 2003-04-24
Abstract: A three-stage process for obtaining metallic Cr units in-situ during the production of stainless steel. Raw chromite ore or a concentrate produced from chromite ore is mixed with a carbonaceous reductant and slagging agents are added to an iron bath (24) for smelting and refining in a refining reactor (10). During the first stage, partially metallized chromite is smelted by carbon in the reactor that is top-and bottom-blown with oxygen and oxygen-containing gases respectively to produce a chromium alloy bath having a carbon content well below saturation. In the second stage, the alloy bath is decarburized by being bottom stirred with the oxygen-containing gas to the final bath carbon specification. In the third stage, the alloy bath is reduced by a metalloid reductant such as silicon or a metallic reductant such as aluminum and again bottom stirred but with a non-oxidizing gas to achieve a high chromium yield. The reactor includes a top lance (18) extending through a throat (14) with a lower portion (20) of the lance extending to a point just above the bath and means (22) such as a tuyere or porous plug mounted at or near a bottom (16) and extending through a refractory lining (12) for stirring the iron bath containing dissolved carbon. Lance (18) includes a central passage for injecting a compact, focused jet oxygen gas (30) that can penetrate through a slag layer (26) for decarburization of the iron bath and an outer passage for discharging an oxygen gas (28) above the bath for post-combustion of CO to CO2. Passage includes a plurality of evenly spaced annular diverging nozzles. The lance also includes a pair of concentric conduits for conducting a coolant. <IMAGE>
Patent DE-69628804-D1 (DE)
Inventor: CHEN YUHPYNG L
IPC: A61P3/08
Filed: 1996-11-07
Granted: 2003-07-31
Abstract: Corticotropin-releasing factor (CRF) antagonists having the formula   <CHEM>     or <CHEM> wherein the dashed lines, A, B, D, E, F, Z, G, R<3>, and R<5> are as defined below, and pharmaceutical compositions containing them.
Patent DE-69636948-D1 (DE)
Inventor: BELFORT GEORGES
IPC: B01D63/06
Filed: 1996-08-02
Granted: 2007-04-19
Abstract: A method and apparatus for achieving reverse osmosis, microfiltration, nanofiltration and ultrafiltration, produces Dean vortices against a membrane surface which is advantageously in a form of a wound helical membrane tube.
Patent DE-69701770-D1 (DE)
Inventor: CURTZE JUERGEN
IPC: A01N43/84
Filed: 1997-06-18
Granted: 2000-05-31
Abstract: Enol ether derivatives of formula (I) are new: Q = (CH2)m or CHR; m = 2-3; R = H, Ph or 1-4C alkyl; Q' = morpholin-4-yl, dimethylamino, methylethylamino or diethylamino; R1 = H, halo, Ph or 1-6C alkyl or alkoxy (optionally substituted by halo); R2, R3 = H, halo or 1-6C alkoxy or alkyl (optionally substituted by halo); and X = O or S. Also claimed is a composition comprising (I) and a carrier and/or an additive.
Patent DE-69710027-D1 (DE)
Inventor: VIGREUX DANIEL
IPC: E05C9/12
Filed: 1997-10-28
Granted: 2002-03-14
Abstract: The long bolt mechanism consists of a housing (1) fitted into a recess in the door or window frame and containing a rotary toothed plate (14) which can be turned through 90 degrees by a handle and a bar (15) with two studs (8) connected to the bolts and a rack (16) meshing with the teeth (17) of the plate (14). The greatest diameter of the toothed plate (14) is more or less equivalent to the width of the mechanism's housing, which has an aperture (18) in one side wall to receive the edge of the plate. The mechanism also has a spring-loaded vane (21) which lies parallel to the direction of the rack's travel and is aligned between the plate's centre of rotation and the points where it meshes with the rack.
Patent DE-69718012-D1 (DE)
Inventor: KARANEWSKY S
IPC: C07K5/06
Filed: 1997-09-12
Granted: 2003-01-30
Abstract: This invention is directed to novel (N-substituted)indole ICE/ced-3-inhibitor compounds. The invention is also directed to pharmaceutical compositions of such indole compounds, plus the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, and for the prevention of ischemic injury.
Patent DE-69718682-D1 (DE)
Inventor: REITER GODFREY
IPC: A61F13/534
Filed: 1997-11-18
Granted: 2003-02-27
Abstract: An absorbent article useful for absorbing bodily fluids discharged by the wearer of the article is provided. The absorbent article comprises a fluid pervious topsheet, a fluid impervious backsheet affixed to the topsheet, an absorbent core disposed between the topsheet and the backsheet, and a resilient tubular member disposed between the topsheet and the backsheet for transporting the fluids to a predetermined region of the core. The tubular member has a plurality of fluid inlets and a plurality of fluid outlets, the inlets and outlets providing fluid communication between the interior and exterior of the tubular member. Discharged fluids may be transported from regions adjacent the inlets into the interior of the tubular member, and thereafter through the outlets to the predetermined regions of the core adjacent the outlets, thereby rapidly transporting the fluids to the predetermined region of the core. The inlets are normally open and the outlets are normally closed, however compression of the tubular member causes the inlets to close and the outlets to open, thereby permitting the desired fluid movement. Decompression and compression of the tubular member may be accomplished by the normal bodily movements of the wearer.
Patent DE-69725956-D1 (DE)
Inventor: LUTHRA SANJAY
IPC: C08G18/50
Filed: 1997-12-05
Granted: 2003-12-11
Abstract: The present invention is directed to an aqueous coating composition having a solids content of 20 to 96% by weight and containinga) a polyisocyanate component which is dispersible in water and has an average NCO functionality of 2 to 6 andb) a polyaspartate corresponding to the formula andc) water, which is present in an amount of at least 4% by weight, based on the solids content of components a) and b), wherein components a) and b) are present in an amount sufficient to provide an equivalent ratio of isocyanate groups to amino groups of at least 0.9:1.
Patent DE-69730119-D1 (DE)
Inventor: GIORDANINO PIERO
IPC: H01H50/16
Filed: 1997-10-21
Granted: 2004-09-09
Abstract: There is described an electromagnetic relay comprising a cover (1) containing a bi-stable test push-button (16), that realizes a temporary and a fixed contact positions; the test push-button (16) is equipped with retainer means (20) to obtain the fixed position by pushing and simultaneously rotating it; and the cover (1) is equipped with means (34) to house the push-button (16) preventing its release in case of fixed closure. Moreover, the cover (39) can be equipped with a slider (40) comprising means (46) to allow temporary pushing and means (42, 44) to allow permanently pushing the push-button (48) into its contact position. <IMAGE>
Patent DE-69730313-D1 (DE)
Inventor: VON EICHEL-STREIBER CHRISTOPH
IPC: A61K48/00
Filed: 1997-01-31
Granted: 2004-09-23
Abstract: A method of treating a disorder characterized by an activating mutation in a Ras proto-oncogene, comprising contacting cells of a patient suffering from the disorder with a protein having the toxic activity of Clostridium sordellii toxin LT under conditions favoring inactivation of Ras by glucosylation of Ras' threonine 35 in said cell. The protein preferably is an immunotoxin that contains as a toxic domain the catalytic domain of toxin LT.
Patent DE-69815678-D1 (DE)
Inventor: REGNIER J
IPC: B32B27/28
Filed: 1998-05-21
Granted: 2003-07-24
Abstract: An oriented co-extruded film suitable for use as a window film for mailing envelopes, having a polyolefin layer and a non-glossy surface layer of polystyrene.
Patent DE-69826267-D1 (DE)
Inventor: HAMILTON GREGORY S
IPC: A61K31/215
Filed: 1998-06-03
Granted: 2004-10-21
Abstract: This invention relates to the use of a non-immunosuppressive neuroimmunophilin FKBP ligand in the manufacture of a medicament for treating alopecia or promoting hair growth. <IMAGE>
Patent DE-69833202-D1 (DE)
Inventor: SORRIBES MICHAEL MIRAVET
IPC: A61F11/00
Filed: 1998-08-12
Granted: 2006-04-06
Abstract: An instrument and use of an instrument serving for correcting the shape of an external ear, for example jug ears, lop ears, cop ears or Stahl's ears. Correction takes place by, from two sides, affecting a chosen zone of the ear for a period of time with forces for giving the cartilage of that zone a permanent deformation. The instrument comprises a matrix and a patrix interconnected by a hinge and made to, from each side, interactingly affect a chosen zone of the ear for a relatively long period of time with forces for giving the cartilage of that zone a permanent deformation. The hinge can by means of a screw be fixed in the correcting position until the deformation of the cartilage is permanent. A deformed ear can by means of the invention more easily and effectively than known per se be corrected non-surgically.
Patent DE-69833894-D1 (DE)
Inventor: NARUSHIMA SHIGEKI
IPC: B21B41/08
Filed: 1998-11-20
Granted: 2006-05-11
Abstract: A high-quality hot rolled steel sheet is manufactured with a high production efficiency and a low cost, from a long, hot slab (801), using a combination of continuous casting facilities, an edger (803) and a plate reduction press machine (802). <IMAGE>
Patent DE-69838953-D1 (DE)
Inventor: LEUNG SHUI-ON
IPC: C12P21/04
Filed: 1998-11-06
Granted: 2008-02-14
Abstract: A method of making a glycosylated antibody or antibody fragment having a reactive ketone group on the glycosylated site is provided. The method comprises expressing a cell transfected with a vector encoding an antibody having one or more glycosylation sites in a culture medium comprising a ketone derivative of a saccharide or saccharide precursor and, in the case of an antibody fragment, fragmenting the resulting antibody into an antigen-binding antibody fragment. Methods of making immunoconjugates comprising the glycosylated antibodies or antibody fragments also are provided, wherein the antibody or antibody fragment is reacted with an agent comprising a ketone-reactive group. Glycosylated antibodies and antibody fragments having a reactive ketone group on the glycosylated site, immunoconjugates comprising such antibodies and antibody fragments and in vivo targeting methods using such antibodies, antibody fragments and immunoconjugates also are provided.
Patent DE-69900465-D1 (DE)
Inventor: KONGSBAK LARS
IPC: C12Q1/68
Filed: 1999-03-05
Granted: 2001-12-20
Abstract: A method for determination of transferase activity is disclosed. The method comprises measuring a change in fluorescence polarization of a fluorescently labeled substance upon transfer to a second compound by the transferase.
Patent DE-69927286-D1 (DE)
Inventor: DALGLEISH ANGUS GEORGE
IPC: A61P37/04
Filed: 1999-12-09
Granted: 2005-10-20
Abstract: This invention is concerned with agents for the treatment of primary, metastatic and residual cancer in mammals (including humans) by inducing the immune system of the mammal or human afflicted with cancer to mount an attack against the tumour lesion. In particular, the invention pertains to the use of whole-cells, derivatives and portions thereof with or without vaccine adjuvants and/or other accessory factors. More particularly, this disclosure describes the use of particular combinations of whole-cells and derivatives and portions thereof that form the basis of treatment strategy.
Patent DE-69930772-D1 (DE)
Inventor: VAN DER MAST WILLEM FRANS
IPC: D01G1/04
Filed: 1999-11-22
Granted: 2006-05-18
Abstract: A device for cutting fibres into pieces, wherein a fibre (10) is divided into pieces (11) by pressing a knife (7) against the fibre (10), said device including a knife roller (2) comprising several substantially axially oriented knives (7) and pressure ribs (8) which are present between the knives (7), and a pressure roller (3), which rollers (2, 3) can be driven in opposite directions at the same peripheral velocity, wherein the knife roller (2) is provided with substantially axially extending mounting sections (19), and in that the pressure ribs (8) are provided on the radially inward side with a recess corresponding to the mounting section (19), which engages round said mounting section (19). <IMAGE>
Patent DE-69936730-D1 (DE)
Inventor: LEWIS DAVID
IPC: A61L9/04
Filed: 1999-11-22
Granted: 2007-09-13
Abstract: In a solution composition for use in an aerosol inhaler which comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility m compound the use of a mixture of HFA 134a and HFA 227 allows to modulate the mass median aerodynamic diameter (MMAD) of the aerosol particles on actuation of the inhaler to target specific regions of the respiratory tract. Moreover the fine particle dose (FPD) of the active ingredient in the composition increases by reducing the metering chamber volume.
Patent DE-69939752-D1 (DE)
Inventor: MARQUIS ROBERT WELLS JR
IPC: A61P33/06
Filed: 1999-12-21
Granted: 2008-11-27
Abstract: The present invention provides 4-amino-azepan-3-one protease inhibitors and pharmaceutically acceptable salts, hydrates and solvates thereof which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, novel intermediates of such compounds, and methods for treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis; gingival disease including gingivitis and periodontitis; arthritis, more specifically, osteoarthritis and rheumatoid arthritis; Paget's disease; hypercalcemia of malignancy; and metabolic bone disease, comprising inhibiting said bone loss or excessive cartilage or matrix degradation by administering to a patient in need thereof a compound of the present invention.
Patent DE-69940829-D1 (DE)
Inventor: ABBOTT AARON
IPC: H04L29/06
Filed: 1999-12-22
Granted: 2009-06-10
Abstract: A system is provided whereby software components acting as servers can be upgraded or installed when new functionality is required without client components which have made requests to these components being made aware of the upgrade initiated by their request. The servers can then respond to requests which would otherwise have caused errors in the client components.
Patent DE-69941627-D1 (DE)
Inventor: HANASH SAMIR M
IPC: C12P21/08
Filed: 1999-11-05
Granted: 2009-12-17
Abstract: The present invention relates to screening methods for diagnosis and prognosis of cancer in a subject by means of detecting increased levels of S100 protein in sera and other biological fluids of the subject. The method of the invention can also be used to identify subjects at risk for developing cancer. The method of the invention involves the use of subject derived serum samples, or other biological fluid samples, to determine the occurrence and level of circulating S100 proteins. The invention also provides screening methods for diagnosis, prognosis, or susceptibility to cancer in a subject by means of detecting the presence of serum autoantibodies to specific S100 protein antigens in sera from subjects. The present invention further provides for kits for carrying out the above described screening methods. Such kits will be used to screen patients for increased levels of S100 protein, or for the detection of autoantibodies to S100 proteins, as a diagnostic and prognostic indicator of disease.
Patent DE-502004001731-D1 (DE)
Inventor: SCHNEIDER GEORG
IPC: B41L47/00
Filed: 2004-02-19
Abstract: The storage device has two storage positions, the second one being below the first one and offset vertically along the length (L) of the incoming elevator (01) to store the elevator released from the holder. An elevator fallen into the second storage position lies on a rest. The feed device takes this elevator to the cylinder in a linear motion parallel to the rest.
Patent DE-502004007169-D1 (DE)
Inventor: SCHILLER DIRK
IPC: F04B37/08
Filed: 2004-07-14
Abstract: A vacuum device comprises a plurality of cryopumps (10) connected with one or a plurality of vacuum chambers. The cryopumps (10) are connected via media supply conduits (12) and media return conduits (14) with a compressor (16). An adjusting device (18) is connected before at least one of the cryopumps for controlling the amount of media fed to the cryopump. Further, the cryopumps (10) comprise a temperature measuring device. The temperature measuring device and the adjusting device (18) are connected with a controller (28). To allow the desired amount of media to be fed to the cryopumps (10), the adjusting device (18) comprises a throttle (24) in a media supply conduit (12) and a controllable valve in a throttle bypass conduit (22).
Patent DE-502004008100-D1 (DE)
Inventor: BECHERT THORSTEN
IPC: A61K33/38
Filed: 2004-08-26
Abstract: The Invention relates to a body care product containing porous particles made of metal containing silver and having an average diameter size of between 1 and 100 μm.
Patent DE-502004012079-D1 (DE)
Inventor: MERK HANS
IPC: B05B1/26
Filed: 2004-04-28
Abstract: The arrangement has a medium storage device, a medium pump and an applicator (1) in which a medium guide is provided and that has an outlet region for medium delivery facing away from the storage device. At least two outlet openings (4) are provided in the outlet region. The outlet openings for the medium delivery are oriented in at least two different main delivery directions.
Patent DE-502005002086-D1 (DE)
Inventor: KYNAST RIGOBERT
IPC: H04L29/12
Filed: 2005-07-23
Abstract: A network slave unit address assignment procedure sends initialisation telegrams with part IP (Internet Protocol) addresses from a master station, sets a slave real time communications address, generates a full address from them and sends them in an answer telegram to the master station. Independent claims are included for network slave and master stations using the procedure.